The neurology diagnostic and monitoring devices market size has grown strongly in recent years. It will grow from $9.32 billion in 2025 to $10.19 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising neurological disorder prevalence, growth in imaging infrastructure, advancements in EEG and MRI systems, increased hospital diagnostics, aging population.
The neurology diagnostic and monitoring devices market size is expected to see strong growth in the next few years. It will grow to $14.38 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to demand for remote patient monitoring, expansion of neurology centers, increasing awareness of brain health, technological advancements in imaging, rising research investments. Major trends in the forecast period include increasing use of portable neurology devices, growing demand for early disease diagnosis, expansion of remote neurological monitoring, rising adoption of non-invasive diagnostic tools, growth in multimodal imaging approaches.
The increasing prevalence of neurodegenerative diseases is increasingly supporting the expansion of the neurology diagnostic and monitoring devices market going forward. Neurodegenerative diseases are characterized by the progressive loss of neuron structure and function in the brain and spinal cord, leading to cognitive and motor decline. The growing prevalence of these conditions is linked to aging populations, longer life expectancy, and increased exposure to genetic and environmental risk factors. Neurology diagnostic and monitoring devices provide real-time and precise assessment of neurological function and disease progression, enabling early diagnosis, personalized treatment planning, and effective monitoring of therapeutic responses. For example, in April 2025, according to the Alzheimer’s Association, a US-based nonprofit organization, more than 7 million Americans were living with Alzheimer’s disease, with projections indicating this number could approach 13 million by 2050. As a result, the rising prevalence of neurodegenerative diseases is reinforcing growth within the neurology diagnostic and monitoring devices market.
Leading companies operating in the neurology diagnostic and monitoring devices market are focusing on advanced solutions such as image-guided therapy systems to improve precision in neurovascular interventions. Image-guided therapy systems support real-time planning, navigation, and execution of therapeutic procedures. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, launched the Azurion neuro biplane system. This platform enhances minimally invasive diagnosis and treatment of neurovascular conditions through advanced imaging flexibility, rapid switching between 2D and 3D views, table-side controls for sterile workflow maintenance, automated beam rotation, and AI-enabled performance monitoring.
In January 2024, Aditxt, Inc., a US-based healthcare company, acquired proprietary EEG monitoring technologies, including NeuroCap and NeuroEEG, from Brain Scientific, Inc. for an undisclosed amount. With this acquisition, Aditxt sought to expand into neurology diagnostics and monitoring by integrating telehealth-enabled EEG systems capable of streamlining testing and interpretation in remote and critical-care environments. Brain Scientific is a US-based provider of neurology diagnostic and monitoring devices.
Major companies operating in the neurology diagnostic and monitoring devices market are Siemens Healthineers, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Shimadzu Corporation, Masimo Corporation, Nihon Kohden Corporation, Elekta AB, Natus Medical Incorporated, Esaote S.p.A., Zynex Medical Inc., Canon Medical Systems Corporation, Neurosoft S.A., Cadwell Industries Inc., Cogito Brains Inc., Blackrock Neurotech Inc., Compumedics Limited, Ceribell Inc., Nexstim Plc, NeuroMetrix Inc., Lumos Labs Inc., Soterix Medical Inc., Advanced Brain Monitoring Inc., Sense Neuro Diagnostics Inc.
North America was the largest region in the neurology diagnostic and monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology diagnostic and monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurology diagnostic and monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the neurology diagnostic and monitoring devices market by raising costs of imaging components, semiconductors, and precision electronics, particularly affecting MRI, CT, and PET systems in Asia-Pacific and Europe. These impacts have slowed procurement cycles for hospitals and diagnostic labs. However, tariffs have encouraged localized assembly, regional partnerships, and supply chain diversification.
The neurology diagnostic and monitoring devices market research report is one of a series of new reports that provides neurology diagnostic and monitoring devices market statistics, including neurology diagnostic and monitoring devices industry global market size, regional shares, competitors with a neurology diagnostic and monitoring devices market share, detailed neurology diagnostic and monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurology diagnostic and monitoring devices industry. This neurology diagnostic and monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurology diagnostic and monitoring devices evaluate disorders of the brain, spinal cord, and nerves, helping detect conditions such as epilepsy, stroke, Alzheimer’s disease, and multiple sclerosis.
The main device categories of neurology diagnostic and monitoring devices include electroencephalogram (EEG) systems, magnetic resonance imaging (MRI) systems, computed tomography (CT) scanners, positron emission tomography (PET) systems, ultrasound imaging systems, and others. EEG systems are devices that detect and record electrical activity in the brain using electrodes placed on the scalp. These systems are used for conditions such as neurodegenerative disorders, epilepsy, stroke, and others. The end users include hospitals and surgical centers, neurology centers, ambulatory care centers, diagnostic laboratories and imaging centers, as well as academic institutions.
The neurology diagnostic and monitoring devices market consists of sales of electromyography (EMG) systems, magnetoencephalography (MEG) systems, functional magnetic resonance imaging (fMRI) systems, and transcranial magnetic stimulation (TMS) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurology diagnostic and monitoring devices market size is expected to see strong growth in the next few years. It will grow to $14.38 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to demand for remote patient monitoring, expansion of neurology centers, increasing awareness of brain health, technological advancements in imaging, rising research investments. Major trends in the forecast period include increasing use of portable neurology devices, growing demand for early disease diagnosis, expansion of remote neurological monitoring, rising adoption of non-invasive diagnostic tools, growth in multimodal imaging approaches.
The increasing prevalence of neurodegenerative diseases is increasingly supporting the expansion of the neurology diagnostic and monitoring devices market going forward. Neurodegenerative diseases are characterized by the progressive loss of neuron structure and function in the brain and spinal cord, leading to cognitive and motor decline. The growing prevalence of these conditions is linked to aging populations, longer life expectancy, and increased exposure to genetic and environmental risk factors. Neurology diagnostic and monitoring devices provide real-time and precise assessment of neurological function and disease progression, enabling early diagnosis, personalized treatment planning, and effective monitoring of therapeutic responses. For example, in April 2025, according to the Alzheimer’s Association, a US-based nonprofit organization, more than 7 million Americans were living with Alzheimer’s disease, with projections indicating this number could approach 13 million by 2050. As a result, the rising prevalence of neurodegenerative diseases is reinforcing growth within the neurology diagnostic and monitoring devices market.
Leading companies operating in the neurology diagnostic and monitoring devices market are focusing on advanced solutions such as image-guided therapy systems to improve precision in neurovascular interventions. Image-guided therapy systems support real-time planning, navigation, and execution of therapeutic procedures. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, launched the Azurion neuro biplane system. This platform enhances minimally invasive diagnosis and treatment of neurovascular conditions through advanced imaging flexibility, rapid switching between 2D and 3D views, table-side controls for sterile workflow maintenance, automated beam rotation, and AI-enabled performance monitoring.
In January 2024, Aditxt, Inc., a US-based healthcare company, acquired proprietary EEG monitoring technologies, including NeuroCap and NeuroEEG, from Brain Scientific, Inc. for an undisclosed amount. With this acquisition, Aditxt sought to expand into neurology diagnostics and monitoring by integrating telehealth-enabled EEG systems capable of streamlining testing and interpretation in remote and critical-care environments. Brain Scientific is a US-based provider of neurology diagnostic and monitoring devices.
Major companies operating in the neurology diagnostic and monitoring devices market are Siemens Healthineers, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Shimadzu Corporation, Masimo Corporation, Nihon Kohden Corporation, Elekta AB, Natus Medical Incorporated, Esaote S.p.A., Zynex Medical Inc., Canon Medical Systems Corporation, Neurosoft S.A., Cadwell Industries Inc., Cogito Brains Inc., Blackrock Neurotech Inc., Compumedics Limited, Ceribell Inc., Nexstim Plc, NeuroMetrix Inc., Lumos Labs Inc., Soterix Medical Inc., Advanced Brain Monitoring Inc., Sense Neuro Diagnostics Inc.
North America was the largest region in the neurology diagnostic and monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology diagnostic and monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurology diagnostic and monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the neurology diagnostic and monitoring devices market by raising costs of imaging components, semiconductors, and precision electronics, particularly affecting MRI, CT, and PET systems in Asia-Pacific and Europe. These impacts have slowed procurement cycles for hospitals and diagnostic labs. However, tariffs have encouraged localized assembly, regional partnerships, and supply chain diversification.
The neurology diagnostic and monitoring devices market research report is one of a series of new reports that provides neurology diagnostic and monitoring devices market statistics, including neurology diagnostic and monitoring devices industry global market size, regional shares, competitors with a neurology diagnostic and monitoring devices market share, detailed neurology diagnostic and monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurology diagnostic and monitoring devices industry. This neurology diagnostic and monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurology diagnostic and monitoring devices evaluate disorders of the brain, spinal cord, and nerves, helping detect conditions such as epilepsy, stroke, Alzheimer’s disease, and multiple sclerosis.
The main device categories of neurology diagnostic and monitoring devices include electroencephalogram (EEG) systems, magnetic resonance imaging (MRI) systems, computed tomography (CT) scanners, positron emission tomography (PET) systems, ultrasound imaging systems, and others. EEG systems are devices that detect and record electrical activity in the brain using electrodes placed on the scalp. These systems are used for conditions such as neurodegenerative disorders, epilepsy, stroke, and others. The end users include hospitals and surgical centers, neurology centers, ambulatory care centers, diagnostic laboratories and imaging centers, as well as academic institutions.
The neurology diagnostic and monitoring devices market consists of sales of electromyography (EMG) systems, magnetoencephalography (MEG) systems, functional magnetic resonance imaging (fMRI) systems, and transcranial magnetic stimulation (TMS) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurology Diagnostic and Monitoring Devices Market Characteristics
3. Neurology Diagnostic and Monitoring Devices Market Supply Chain Analysis
4. Global Neurology Diagnostic and Monitoring Devices Market Trends and Strategies
5. Neurology Diagnostic and Monitoring Devices Market Analysis of End Use Industries
7. Global Neurology Diagnostic and Monitoring Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurology Diagnostic and Monitoring Devices Total Addressable Market (TAM) Analysis for the Market
9. Neurology Diagnostic and Monitoring Devices Market Segmentation
10. Neurology Diagnostic and Monitoring Devices Market Regional and Country Analysis
11. Asia-Pacific Neurology Diagnostic and Monitoring Devices Market
12. China Neurology Diagnostic and Monitoring Devices Market
13. India Neurology Diagnostic and Monitoring Devices Market
14. Japan Neurology Diagnostic and Monitoring Devices Market
15. Australia Neurology Diagnostic and Monitoring Devices Market
16. Indonesia Neurology Diagnostic and Monitoring Devices Market
17. South Korea Neurology Diagnostic and Monitoring Devices Market
18. Taiwan Neurology Diagnostic and Monitoring Devices Market
19. South East Asia Neurology Diagnostic and Monitoring Devices Market
20. Western Europe Neurology Diagnostic and Monitoring Devices Market
21. UK Neurology Diagnostic and Monitoring Devices Market
22. Germany Neurology Diagnostic and Monitoring Devices Market
23. France Neurology Diagnostic and Monitoring Devices Market
24. Italy Neurology Diagnostic and Monitoring Devices Market
25. Spain Neurology Diagnostic and Monitoring Devices Market
26. Eastern Europe Neurology Diagnostic and Monitoring Devices Market
27. Russia Neurology Diagnostic and Monitoring Devices Market
28. North America Neurology Diagnostic and Monitoring Devices Market
29. USA Neurology Diagnostic and Monitoring Devices Market
30. Canada Neurology Diagnostic and Monitoring Devices Market
31. South America Neurology Diagnostic and Monitoring Devices Market
32. Brazil Neurology Diagnostic and Monitoring Devices Market
33. Middle East Neurology Diagnostic and Monitoring Devices Market
34. Africa Neurology Diagnostic and Monitoring Devices Market
36. Neurology Diagnostic and Monitoring Devices Market Competitive Landscape and Company Profiles
37. Neurology Diagnostic and Monitoring Devices Market Other Major and Innovative Companies
40. Neurology Diagnostic and Monitoring Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Neurology Diagnostic And Monitoring Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurology diagnostic and monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurology diagnostic and monitoring devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurology diagnostic and monitoring devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Electroencephalogram (EEG) Systems; Magnetic Resonance Imaging (MRI) Systems; Computed Tomography (CT) Scanner; Position Emission Tomography (PET) System; Ultrasound Imaging Systems; Other Device Types2) By Indication: Neurodegenerative Disease; Epilepsy; Stroke; Other Indications
3) By End-User: Hospitals And Surgery Centers; Neurology Centers; Ambulatory Care Centers; Diagnostic Laboratories And Imaging Centers; Research Laboratories And Academic Institutes
Subsegments:
1) By Electroencephalogram (EEG) Systems: Portable EEG Systems; Clinical EEG Systems; Wireless EEG Systems2) By Magnetic Resonance Imaging (MRI) Systems: Closed MRI Systems; Open MRI Systems; Functional MRI (fMRI) Systems
3) By Computed Tomography (CT) Scanner: Standard CT Scanners; High-Definition CT Scanners; 3D CT Scanners
4) By Position Emission Tomography (PET) System: PET-CT Scanners; PET-MRI Scanners
5) By Ultrasound Imaging Systems: Diagnostic Ultrasound Systems; 3D And 4D Ultrasound Systems; Portable Ultrasound Systems
6) By Other Device Types: Nerve Conduction Study (NCS) Devices; Evoked Potential (EP) Systems; Brain Implants And Neurostimulators
Companies Mentioned: Siemens Healthineers; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Shimadzu Corporation; Masimo Corporation; Nihon Kohden Corporation; Elekta AB; Natus Medical Incorporated; Esaote S.p.A.; Zynex Medical Inc.; Canon Medical Systems Corporation; Neurosoft S.A.; Cadwell Industries Inc.; Cogito Brains Inc.; Blackrock Neurotech Inc.; Compumedics Limited; Ceribell Inc.; Nexstim Plc; NeuroMetrix Inc.; Lumos Labs Inc.; Soterix Medical Inc.; Advanced Brain Monitoring Inc.; Sense Neuro Diagnostics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurology Diagnostic and Monitoring Devices market report include:- Siemens Healthineers
- Koninklijke Philips N.V.
- GE HealthCare Technologies Inc.
- Shimadzu Corporation
- Masimo Corporation
- Nihon Kohden Corporation
- Elekta AB
- Natus Medical Incorporated
- Esaote S.p.A.
- Zynex Medical Inc.
- Canon Medical Systems Corporation
- Neurosoft S.A.
- Cadwell Industries Inc.
- Cogito Brains Inc.
- Blackrock Neurotech Inc.
- Compumedics Limited
- Ceribell Inc.
- Nexstim Plc
- NeuroMetrix Inc.
- Lumos Labs Inc.
- Soterix Medical Inc.
- Advanced Brain Monitoring Inc.
- Sense Neuro Diagnostics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.19 Billion |
| Forecasted Market Value ( USD | $ 14.38 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
